Physician profile
Resham Datta
NPI 1902242597
$1,178.13
in general payments reported to CMS, 2019-2025
17 companies · $42.03 in 2025
The $42.03 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $110 · 2021: $286 · 2022: $272 · 2024: $175 · 2025: $42.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $175.31 | 2024 | Terlivaz |
| Nevro Corp. | $163.38 | 2019-2020 | |
| Medtronic USA, INC. | $146.05 | 2019 | |
| Spr Therapeutics, INC | $114.51 | 2022 | |
| Scilex Pharmaceuticals INC. | $96.63 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.48 | 2020-2022 | |
| Pacira Therapeutics, INC. | $91.27 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $56.28 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $53.05 | 2021 | |
| Boston Scientific Corporation | $42.03 | 2025 | Lux-Dx Insertable Cardiac Monitor, Wavewriter Alpha Prime 16 |
| Almatica Pharma LLC | $31.19 | 2021 | |
| Fidia Pharma USA INC. | $28.30 | 2020-2021 | |
| Protega Pharmaceutials INC | $23.24 | 2022 | |
| Medtronic, INC. | $20.55 | 2021 | |
| Ibsa Pharma INC. | $17.77 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $14.47 | 2021 | |
| International Rehabilitative Sciences, INC | $11.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Resham Datta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.